3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Prostatic Neoplasms
12
Burkitt Lymphoma
12
Lymphoma, Large B-Cell, Diffuse
11
Lymphoma, Follicular
8
Lymphoma, Non-Hodgkin
6
Lymphoma
6
Neoplasms
5
Prostatic Neoplasms, Castration-Resistant
4
Precursor Cell Lymphoblastic Leukemia-Lymphoma
4
Leukemia
3
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
2
Plasmablastic Lymphoma
2
Lymphoproliferative Disorders
2
Lymphoma, T-Cell
2
Lymphoma, B-Cell, Marginal Zone
2
Lymphoma, B-Cell
2
Leukemia, Lymphocytic, Chronic, B-Cell
2
Triple Negative Breast Neoplasms
1
Recurrence
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Ovarian Neoplasms
1
Multiple Myeloma
1
Multi-centric Castleman's Disease
1
Metastatic Castration-sensitive Prostate Cancer
1
Metastatic Castration-resistant Prostate Neoplasms
1
Macular dystrophy, corneal type 1
1
Lymphadenopathy
1
Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8
1
Leukemia, Hairy Cell
1
Leukemia, Biphenotypic, Acute
1
Interventions
Nivolumab
19
pembrolizumab
17
Ipilimumab
13
Specimen Handling
12
Magnetic Resonance Spectroscopy
7
CTLA-4 Antigen
6
binimetinib
5
Opdualag
5
trametinib
4
relatlimab
4
dabrafenib
3
Standard of Care
3
Paclitaxel
3
Introns
3
Interferon alpha-2
3
Gemcitabine
3
Blood Specimen Collection
3
ulixertinib
2
sargramostim
2
lenvatinib
2
fludarabine phosphate
2
fludarabine
2
encorafenib
2
capivasertib
2
cabozantinib
2
atezolizumab
2
aldesleukin
2
X-Rays
2
Taxes
2
Radiosurgery
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Melanoma
×
Prednisone
×
30 days
×
Clear all
No trials found.